Cargando…

Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective

Aldosterone not only contributes to salt and water homeostasis, but also exerts direct cardiovascular and renal effects. Numerous experimental and clinical studies indicate that aldosterone participate in cardiac alterations associated with hypertension, heart failure, diabetes and other pathologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahera, V., Cachofeiro, V., Balfagon, G., Rodicio, J.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2006
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917370/ https://www.ncbi.nlm.nih.gov/pubmed/16604252 http://dx.doi.org/10.1100/tsw.2006.68

Ejemplares similares

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade
por: Martín-Fernández, Beatriz, et al.
Publicado: (2014)

The role of aldosterone blockade in murine lupus nephritis
por: Monrad, Seetha U, et al.
Publicado: (2008)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage
por: Martinez-Martinez, Ernesto, et al.
Publicado: (2016)

SAT-541 Difference in Aldosterone Dependency Between Cardiovascular Diseases and Renal Impairments in Patients with Primary Aldosteronism
por: Sone, Masakatsu, et al.
Publicado: (2020)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Aldosterone receptor antagonists: current perspectives and therapies
por: Guichard, Jason L, et al.
Publicado: (2013)

TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt
por: Rios, Francisco J., et al.
Publicado: (2022)

The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial
por: Minakuchi, Hitoshi, et al.
Publicado: (2020)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
por: Cannavo, Alessandro, et al.
Publicado: (2018)

Aldosterone Blockade in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
por: Chen, Qiao, et al.
Publicado: (2021)

Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up
por: Buglioni, Alessia, et al.
Publicado: (2015)

Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats
por: Martín-Fernández, Beatriz, et al.
Publicado: (2016)

Primary aldosteronism: A Japanese perspective
por: Satoh, Fumitoshi, et al.
Publicado: (2011)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

FRI143 Serum Aldosterone Levels Predict Decline In Renal Function After Unilateral Adrenalectomy For Primary Aldosteronism
por: Stumpf, Matheo A M, et al.
Publicado: (2023)

Illness perspectives in patients with primary aldosteronism
por: Ragnarsson, Oskar, et al.
Publicado: (2022)

Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension
por: Hong, Mo-Na, et al.
Publicado: (2016)

Proanthocyanidins Maintain Cardiac Ionic Homeostasis in Aldosterone-Induced Hypertension and Heart Failure
por: de las Heras, Natalia, et al.
Publicado: (2021)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?
por: Musacchio, L., et al.
Publicado: (2022)

Aldosterone-induced cardiac damage in primary aldosteronism depends on its subtypes
por: Higuchi, Satoshi, et al.
Publicado: (2020)

Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
por: Cooper, Samantha L., et al.
Publicado: (2021)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
por: Gorini, Stefania, et al.
Publicado: (2019)

MON-193 Glucocorticoid Excess and Its Association with Metabolic and Cardiovascular Complications in Primary Aldosteronism
por: zhu, Ke ying, et al.
Publicado: (2020)

The Relationship Between Renal Stones and Primary Aldosteronism
por: Chang, Chun-Kai, et al.
Publicado: (2022)

Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism
por: Amar, Laurence, et al.
Publicado: (2010)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Genetics of Primary Aldosteronism
por: Scholl, Ute I.
Publicado: (2022)

Aldosterone Antagonists Reduce the Risk of Cardiovascular Mortality in Dialysis Patients: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2019)

COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos?
por: Pallarés Carratalá, V., et al.
Publicado: (2020)

Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care
por: Ariens, Joshua, et al.
Publicado: (2022)

Renal dysfunction in cardiovascular diseases and its consequences
por: Deferrari, Giacomo, et al.
Publicado: (2020)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
por: Hu, Jinbo, et al.
Publicado: (2021)

Early influences on cardiovascular and renal development
por: Geelhoed, J. J. Miranda, et al.
Publicado: (2010)

Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases
por: Nwia, Sarah M., et al.
Publicado: (2023)

Role of MicroRNAs in Renin-Angiotensin-Aldosterone System-Mediated Cardiovascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2015)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4o4sulqm935eif27q3g6uu05pk